Katalin Olasz

449 total citations
21 papers, 355 citations indexed

About

Katalin Olasz is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Katalin Olasz has authored 21 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Rheumatology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Katalin Olasz's work include T-cell and B-cell Immunology (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immunotherapy and Immune Responses (5 papers). Katalin Olasz is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immunotherapy and Immune Responses (5 papers). Katalin Olasz collaborates with scholars based in Hungary, United States and Netherlands. Katalin Olasz's co-authors include Tibor T. Glant, Katalin Mikecz, Ferenc Boldizsár, Tibor A. Rauch, Marianna Radács, Anna László, Tamás Czömpöly, Katalin Kis‐Tóth, Péter Balogh and Pèter Németh and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and International Journal of Molecular Sciences.

In The Last Decade

Katalin Olasz

21 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katalin Olasz Hungary 11 185 101 93 62 55 21 355
J.A. van Roon Netherlands 8 160 0.9× 188 1.9× 97 1.0× 75 1.2× 53 1.0× 19 420
Ann‐Katrin Clauder Germany 6 155 0.8× 43 0.4× 72 0.8× 58 0.9× 47 0.9× 7 320
Christina Gerstner Sweden 9 287 1.6× 223 2.2× 125 1.3× 73 1.2× 122 2.2× 12 500
Belinda Baltus Netherlands 9 185 1.0× 158 1.6× 95 1.0× 113 1.8× 32 0.6× 11 409
Bohdan P. Harvey United States 11 245 1.3× 44 0.4× 107 1.2× 54 0.9× 84 1.5× 20 411
Junpei Itoh Japan 10 139 0.8× 110 1.1× 99 1.1× 46 0.7× 70 1.3× 13 342
Anna-Karin B. Lindqvist Sweden 8 245 1.3× 203 2.0× 66 0.7× 65 1.0× 90 1.6× 8 400
Debbie Roeleveld Netherlands 9 146 0.8× 115 1.1× 183 2.0× 67 1.1× 28 0.5× 15 422
Allison Sang United States 8 369 2.0× 252 2.5× 102 1.1× 68 1.1× 42 0.8× 8 477
Sun-Ok Yoon United States 10 283 1.5× 29 0.3× 87 0.9× 58 0.9× 26 0.5× 14 409

Countries citing papers authored by Katalin Olasz

Since Specialization
Citations

This map shows the geographic impact of Katalin Olasz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katalin Olasz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katalin Olasz more than expected).

Fields of papers citing papers by Katalin Olasz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katalin Olasz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katalin Olasz. The network helps show where Katalin Olasz may publish in the future.

Co-authorship network of co-authors of Katalin Olasz

This figure shows the co-authorship network connecting the top 25 collaborators of Katalin Olasz. A scholar is included among the top collaborators of Katalin Olasz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katalin Olasz. Katalin Olasz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olasz, Katalin, et al.. (2025). Proteasome Inhibitors: Potential in Rheumatoid Arthritis Therapy?. International Journal of Molecular Sciences. 26(7). 2943–2943. 2 indexed citations
2.
Olasz, Katalin, Béla Kajtár, Tamás Kiss, et al.. (2024). Splenectomy at early stage of autoimmune arthritis delayed inflammatory response and reduced joint deterioration in mice. Clinical & Experimental Immunology. 216(3). 240–251. 3 indexed citations
3.
Olasz, Katalin & Ferenc Boldizsár. (2024). Recombinant Human Proteoglycan Aggrecan‐G1 Domain‐induced Arthritis (GIA) Mouse Model. Current Protocols. 4(5). e1053–e1053. 1 indexed citations
4.
Olasz, Katalin, et al.. (2024). The Spleen Modulates the Balance of Natural and Pathological Autoantibodies in a Mouse Model of Autoimmune Arthritis. International Journal of Molecular Sciences. 25(21). 11683–11683. 1 indexed citations
5.
Olasz, Katalin, Diána Simon, Péter Balogh, et al.. (2023). Natural and Pathological Autoantibodies Show Age-Related Changes in a Spontaneous Autoimmune Mouse (NZB) Model. International Journal of Molecular Sciences. 24(12). 9809–9809. 2 indexed citations
6.
Olasz, Katalin, et al.. (2022). Splenectomy modulates the immune response but does not prevent joint inflammation in a mouse model of RA. Clinical & Experimental Immunology. 209(2). 201–214. 9 indexed citations
7.
8.
Olasz, Katalin, Bálint Botz, Tamás Kiss, et al.. (2020). Ameliorated Autoimmune Arthritis and Impaired B Cell Receptor-Mediated Ca2+ Influx in Nkx2-3 Knock-out Mice. International Journal of Molecular Sciences. 21(17). 6162–6162. 9 indexed citations
9.
Olasz, Katalin, et al.. (2019). ZAP-70 Regulates Autoimmune Arthritis via Alterations in T Cell Activation and Apoptosis. Cells. 8(5). 504–504. 14 indexed citations
10.
Olasz, Katalin, et al.. (2016). Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis. Mediators of Inflammation. 2016. 1–11. 75 indexed citations
11.
Boldizsár, Ferenc, et al.. (2016). FTY720 (Gilenya) treatment prevents spontaneous autoimmune myocarditis and dilated cardiomyopathy in transgenic HLA-DQ8-BALB/c mice. Cardiovascular Pathology. 25(5). 353–361. 4 indexed citations
12.
Olasz, Katalin, et al.. (2014). Proteoglycan Aggrecan Conducting T Cell Activation and Apoptosis in a Murine Model of Rheumatoid Arthritis. BioMed Research International. 2014. 1–13. 16 indexed citations
13.
Kis‐Tóth, Katalin, Marianna Radács, Katalin Olasz, et al.. (2012). Arthritogenic T cells drive the recovery of autoantibody-producing B cell homeostasis and the adoptive transfer of arthritis in SCID mice. International Immunology. 24(8). 507–517. 3 indexed citations
14.
Glant, Tibor T., Marianna Radács, Katalin Olasz, et al.. (2011). Proteoglycan‐induced arthritis and recombinant human proteoglycan aggrecan G1 domain–induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis. Arthritis & Rheumatism. 63(5). 1312–1321. 52 indexed citations
15.
Radács, Marianna, Katalin Olasz, Gábor Hutás, et al.. (2011). TSG-6 Protein, a Negative Regulator of Inflammatory Arthritis, Forms a Ternary Complex with Murine Mast Cell Tryptases and Heparin. Journal of Biological Chemistry. 286(26). 23559–23569. 34 indexed citations
16.
Czömpöly, Tamás, et al.. (2011). Transcription Factor Nkx2-3 Controls the Vascular Identity and Lymphocyte Homing in the Spleen. The Journal of Immunology. 186(12). 6981–6989. 24 indexed citations
17.
Olasz, Katalin, Ferenc Boldizsár, Katalin Kis‐Tóth, et al.. (2011). T cell receptor (TCR) signal strength controls arthritis severity in proteoglycan-specific TCR transgenic mice. Clinical & Experimental Immunology. 167(2). 346–355. 11 indexed citations
18.
Angyal, Adrienn, Colt A. Egelston, Katalin Olasz, et al.. (2010). Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints. Arthritis Research & Therapy. 12(2). R44–R44. 19 indexed citations
19.
Boldizsár, Ferenc, et al.. (2010). Impaired activation‐induced cell death promotes spontaneous arthritis in antigen (cartilage proteoglycan)–specific T cell receptor–transgenic mice. Arthritis & Rheumatism. 62(10). 2984–2994. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.A. van Roon Breakdown of academic impact, for papers by Ann‐Katrin Clauder Breakdown of academic impact, for papers by Christina Gerstner Breakdown of academic impact, for papers by Belinda Baltus Breakdown of academic impact, for papers by Bohdan P. Harvey Breakdown of academic impact, for papers by Junpei Itoh Breakdown of academic impact, for papers by Anna-Karin B. Lindqvist Breakdown of academic impact, for papers by Debbie Roeleveld Breakdown of academic impact, for papers by Allison Sang Breakdown of academic impact, for papers by Sun-Ok Yoon
Rankless by CCL
2026